- Home
- / Vivos Therapeutics
Vivos Therapeutics
Stock Price
$0.3
2023-08-31
Market Capitalization
$7.5 M
2023-08-31
Revenue
$16 M
FY, 2022
Vivos Therapeutics Summary
Company Summary
- Overview
- Vivos Therapeutics is a company that specializes in the treatment of sleep and breathing disorders. It offers Vivos System, a non-surgical, non-invasive, non-pharmaceutical solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA).
- Type
- Public
- Status
- Active
- Founded
- 2013
- HQ
- Highlands Ranch, CO, US | view all locations
- Website
- https://vivos.com/
- Cybersecurity rating
Table of Contents
Key People
Edward Loew, Investor Relations Officer, Head of Capital Markets
Nick Degenarro, Senior Vice President, Medical Integration Division
Operating MetricsView all
Patients
15K
Q3, 2020
Dentists Served
1.2K
Q3, 2020
Vivos Therapeutics Financials
Summary Financials
- Revenue (Q2, 2023)
- $3.4M
- Gross profit (Q2, 2023)
- $2.1M
- Net income (Q2, 2023)
- ($5.5M)
- Cash (Q2, 2023)
- $3.9M
- EBIT (Q2, 2023)
- ($4.5M)
- Enterprise value
- $5.3M